Culture and Global Health

Rice, Zoe Sanipreeya; Liamputtong, Pranee

doi:10.1007/978-3-030-45009-0_56

Cited by 1 publication

(1 citation statement)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 46 This lack of adjustment may lead to potential biases in the estimated burden of disease, as the same health state may be perceived differently across different cultures or regions. 47 Moreover, the DALY method assumes that a year of healthy life is equally valuable at all ages, hence age-standardised DALYs were used instead to minimise the value difference across age groups. Finally, it is worth noting that the data used is up to the year 2019, that is before COVID-19, hence forecasting estimates for the next 5 years may be conservative provided the COVID-19 comorbidity.…”

Section: Discussionmentioning

confidence: 99%

Estimating the indirect economic burden of cancer in Jordan: a retrospective observational study

Rashdan

2024

BMJ Open

View full text Add to dashboard Cite

ObjectiveThe aim of this study is to estimate the indirect economic burden of 22 cancer types in Jordan using both the human capital approach (HCA) and the value of a statistical life year (VSLY) approach. Additionally, this study aims to forecast the burden of these cancers for the next 5 years while employing time series analysis.DesignRetrospective observational study with a time series analysis.ParticipantsDisability adjusted life years records from the IHME Global Burden Disease estimates 2019 data.Primary outcome measureIndirect economic burden of cancer in Jordan.ResultsThe mean total economic burden for all cancers is estimated to be $1.82 billion using HCA and $3.13 billion using VSLY approach. The cancers contributing most to the total burden are ‘tracheal, bronchus and lung cancer’ ($359.5 million HCA, $618.3 million VSLY), followed by ‘colon and rectum cancer’ ($300.6 million HCA, $517.1 million VSLY) and ‘breast cancer’ ($292.4 million HCA, $502.9 million VSLY). The indirect economic burden ranged from 1.4% to 2.1% of the gross domestic product (GDP) using the HCA, and from 2.3% to 3.6% of the GDP using the VSLY approach. The indirect economic burden is expected to reach 2.3 and 3.5 billion Intl$ by the year 2025 using the HCA and VSLY approach, respectively.ConclusionThe indirect economic burden of cancer in Jordan amounted to 1.4%–3.6% of total GDP, with tracheal, bronchus and lung cancer; colon and rectum cancer; and breast cancer contributing to over 50% of the total burden. This will help set national cancer spending priorities following Jordan’s economic modernisation vision with regard to maximising health economic outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Estimating the indirect economic burden of cancer in Jordan: a retrospective observational study

Rashdan

2024

BMJ Open

View full text Add to dashboard Cite

show abstract

Culture and Global Health

Cited by 1 publication

References 43 publications

Estimating the indirect economic burden of cancer in Jordan: a retrospective observational study

Estimating the indirect economic burden of cancer in Jordan: a retrospective observational study

Contact Info

Product

Resources

About